Federal Circuit Affirms Invalidity of UV Sterilization Patent in Neister v. Eden Park

📄 View Full Report 📥 Export PDF 🔗 Share ⭐ Save

📋 Case Summary

Case NameNeister v. Eden Park Illumination
Case Number24-1374 (Fed. Cir.)
CourtFederal Circuit, Appeal from District of Columbia
DurationJan 2024 – Jan 2026 2 years
OutcomeDefendant Win — Invalidity Affirmed
Patent at Issue
Technology at IssueUV Sterilization Apparatus & Method

Case Overview

The Parties

⚖️ Plaintiff

Individual inventor-patentee asserting rights in UV sterilization technology, a sector that experienced significant commercial expansion.

🛡️ Defendant

Company operating in the photonics and UV lighting space, with product lines relevant to disinfection markets.

Patent at Issue

This landmark case involved the validity of a key utility patent covering UV-based air and surface sterilization technology. Utility patents are registered with the U.S. Patent and Trademark Office (USPTO) and protect functional inventions rather than ornamental appearance.

  • US 9,700,642 B2 — Method and apparatus for sterilizing and disinfecting air and surfaces and protecting a zone from external microbial contamination
🔍

Developing UV sterilization technology?

Check if your UV sterilization product might face invalidity challenges from prior art before launch.

Run FTO Check →

The Verdict & Legal Analysis

Outcome

The Federal Circuit issued a clean affirmance in Case No. 24-1374, upholding the prior tribunal’s ruling on patentability grounds. This outcome means US9700642B2 was found invalid, with no damages or injunctive relief awarded.

Key Legal Issues

The Federal Circuit’s analysis centered on the patentability of US9700642B2, specifically addressing invalidity challenges under statutory grounds such as 35 U.S.C. §§ 102 and 103 (anticipation and obviousness) or 35 U.S.C. § 112 (written description, enablement, and definiteness). The affirmance indicates that the invalidity case, likely built on extensive prior art in UV-C disinfection systems, was well-supported and no reversible error was found in the lower court’s determination.

⚠️

Freedom to Operate (FTO) Analysis

This case highlights critical IP risks in UV sterilization technology. Choose your next step:

📋 Understand This Case’s Impact

Learn about the specific invalidity risks and implications from this litigation.

  • View all related prior art in the UV sterilization space
  • See which companies are most active in UV patents
  • Understand claim construction patterns for similar technologies
📊 View Patent Landscape
⚠️
High Invalidity Risk

For overly broad UV sterilization claims

📋
Extensive Prior Art

In UV-C disinfection systems

Design Freedom for Some

Previously constrained technology areas

✅ Key Takeaways

For Patent Attorneys & Litigators

Federal Circuit affirmed invalidity of UV sterilization patent US9700642B2 in Case No. 24-1374.

Search related case law →

Invalidity/Cancellation Actions remain a highly effective defense strategy in antimicrobial technology patent disputes.

Explore precedents →
🔒
Unlock IP & R&D Team Recommendations
Get actionable strategies for patent portfolio management, FTO analysis, and exploiting new design freedom in UV sterilization.
Validity Audits FTO Best Practices New Design Freedom
Explore Full Analysis in PatSnap Eureka

Frequently Asked Questions

Ready to Strengthen Your Patent Strategy?

Join 18,000+ IP professionals using PatSnap Eureka to conduct prior art searches, draft patents, and analyse competitive landscapes with AI-powered precision.

PatSnap IP Intelligence Team

Patent Research & Competitive Intelligence · PatSnap

This analysis was produced by the PatSnap IP Intelligence Team — a group of patent analysts, IP strategists, and data scientists who work daily with PatSnap’s global patent database of over 2 billion structured data points across patents, litigation records, scientific literature, and regulatory filings.

The team specialises in tracking landmark litigation outcomes, translating complex court rulings into actionable IP strategy, and identifying the competitive intelligence implications for R&D and legal teams. All case analysis is grounded in primary sources: official court records, USPTO filings, and Federal Circuit opinions.

📊 2B+ Patent Data Points 🌍 120+ Countries Covered 🏢 18,000+ Customers Worldwide ⚖️ Global Litigation Database 🔍 Primary Source Verified
⚖️ Disclaimer: This article is for informational purposes only and does not constitute legal advice. The analysis presented reflects publicly available case information and general legal principles. For specific advice regarding patent litigation, FTO analysis, or IP strategy, please consult a qualified patent attorney.